Explore the PACE-B trial results on SBRT for prostate cancer, offering a convenient, cost-effective alternative to conventional radiotherapy.
Thus, the reduction of the number of fractions and the increase of the dose/fraction seem to be reasonable choices in the treatment of this cancer. This review reported the technology evolution, the radiobiological and the clinical data about the role of extreme hypofractionated RT in the ...
Savita Dandapani, MD, PhD, discussed combining radium-223 and SBRT for metastatic castration-sensitive prostate cancer.
"Active surveillance" (AS) refers to the strict follow-up of indolent PC in young men, leaving the possibility of a curative treatment in case of evolution to an aggressive cancer. The only active treatment that has been compared to watchful waiting in a contemporary randomized trial is ...
The first reports on long-term outcomes of stereotactic body radiotherapy (SBRT) demonstrate that this treatment is both safe and effective for low-risk prostate cancer. “The benefits [of SBRT] are numerous and far reaching, and include greater patient convenience and diminished impact on quality...
Of patients who were sexually potent prior to treatment, 79% maintained potency at 2 years post-treatment. Conclusions SBRT for clinically localized prostate cancer was well tolerated, with an early biochemical response similar to other radiation therapy treatments. Benign PSA bounces were common. ...
Background: Recent data have found an overall survival benefit from prostate-directed radiotherapy in patients with low-volume metastatic prostate cancer. Prostate SBRT is an attractive treatment in this setting and may be optimised with MR-guided adaptive treatment. Here, we share our institutional ...
Optimising treatment outcomes using Stereotactic Body Radiotherapy (SBRT) for prostate cancer 来自 Semantic Scholar 喜欢 0 阅读量: 33 作者:Murray,L Janet 摘要: Aims: to optimise linear accelerator-based prostate stereotactic ablative radiotherapy (SABR) through planning studies, tumour control probability...
Stereotactic body radiation therapy (SBRT) is gaining momentum for its clinical application of the treatment of localized prostate cancer. The use of SBRT is becoming a viable alternative with preliminary clinical trials and single institutions reporting equal or superior biochemical recurrence rates to ...
In the first option, patients undergo about20 radiotherapy sessions over 4 weeks. Boosted or ultra-fractionated radiotherapy is given in just5 sessions or less. This treatment is also called stereotactic beam therapy (SBRT) or stereotactic radioablation (SABR). ...